ResCom

The two abstracts awarded the Best Investigator-Initiated Study Awards at ECCO’26 reflect a move toward implementing precision medicine in routine care, using biomarker-based strategies to stratify patient risk and guide treatment in IBD.ol

The 8th EpiCom Workshop, held during the recent ECCO Congress in Stockholm, brought together leading experts in IBD epidemiology from across the globe. The workshop addressed two of the most pressing challenges currently facing the field: the rapid global rise in IBD incidence and the persistent inequalities in access to care. Structured into two distinct sessions, each comprising a series of expert presentations and interactive discussions, the workshop offered a comprehensive and multidimensional perspective on the evolving IBD landscape.

Within ECCO, two committees have played a pivotal and complementary role in advancing the scientific understanding and clinical management of IBD: the Epidemiological Committee (EpiCom) and the Clinical Research Committee (ClinCom). As both bodies now merge into the newly established Research Committee (ResCom), this report offers a concise reflection on their key contributions and lasting legacy.